HelpDesk
sign in

Preliminary 2024 MY Clinical Quality Measure Results for Medical Group Review

Creation date: 4/13/2022 9:38 AM    Updated: 5/11/2025 10:33 PM
Print...
UPDATE 5/12/2025: DEPRESSION CARE 6-MONTH AND 12-MONTH OUTCOME MEASURES ADDED FOR REVIEW

This is your official opportunity to review and comment on the preliminary clinical quality performance measure results for your medical group.

2024 dates of service are reflected in these results unless otherwise noted.

Measures and Reporting
Measures included in this review are the following:

  • Adolescent Mental Health and/or Depression Screening
  • Colorectal Cancer Screening
  • Depression PHQ-9/PHQ-9M Utilization – Adult Population*
  • Depression PHQ-9/PHQ-9M Utilization – Adolescent Population*
  • Optimal Asthma Control – Adult Population
  • Optimal Asthma Control – Child Population
  • Optimal Diabetes Care
  • Optimal Vascular Care
  • Depression Care 6- and 12-month Outcome Measures - Adult Population**
  • Depression Care 6- and 12-month Outcome Measures - Adolescent Population**

*Measurement Period 09/01/2024-12/31/2024.
**Denominator Identification Period: 11/1/2022-10/31/2023; 6-month Numerator Period: 3/2/2023-6/29/2024, 12-month Numerator Period: 9/2/2023-12/30/2024

Measures are reported at the clinic and medical group levels. They are calculated from data abstracted and submitted by clinics and are independently validated by MN Community Measurement (MNCM). Measures that are part of MNCM’s measure reporting slate are included in this review.

Results Review and Public Reporting
Data files for review are attached to this article. Medical groups included in the review file should have received an email with the file password. Please contact MNCM at support@mncm.org if you did not receive the email.

Please note that the results in the data files are preliminary and are not final until all data validation, including this review period, are complete. Also, please note that the review files and results are considered confidential.

This review includes results of clinics and medical groups that participated in the 2024 MY Regular Cycle and that will be publicly reported. To be publicly reported, a clinic must meet data reliability standards by having at least thirty eligible patients. Data from all clinics – both publicly reported and not – are included in the rolled up medical group and statewide rates. Clinics and medical groups that will participate in the 2024 MY Mid-Year Cycle will review their preliminary results separately.

Performance ratings (e.g., Top, Above Average, Average, Below Average) are not included in this review but will be available for preview prior to public reporting of final risk adjusted results. Risk adjustment will occur after completion of the Mid-Year Cycle in the Fall of 2025. Public reporting of results will occur in late 2025.

Comment Process
Comments, questions and other feedback will be accepted until the following dates and times via email at support@mncm.org or phone at 612-746-4522:

  • 5:00 p.m. on Friday, May 16 for all measures except Depression Care 6-month and 12-month Outcome Measures
  • 5:00 p.m. on Friday, May 23 for Depression Care 6-month and 12-month Outcome Measures
 
Each medical group is responsible for reviewing its own preliminary results, investigating any concerns, and submitting evidence to MNCM if a change in results is requested. In that event, MNCM staff will review the information provided and decide whether to publicly report the results based upon the evidence submitted.

Appeals Process
If our decision does not favor the medical group/clinic, a formal written appeal may be submitted. Medical groups have two weeks from the date of our decision to submit a formal appeal. Supporting evidence must be submitted with the appeal.

Only concerns about publicly reported results are subject to appeal. It is extremely rare for MNCM to change performance results unless a medical group/clinic provides evidence of an error, or a pattern of data errors can be identified by MNCM based on multiple comments. Feedback regarding the definition of a measure, patient attribution methodology, or other data collection methods are not subject to appeal; however, they will be forwarded to the appropriate board committee for review.

Appeals must be submitted in writing (email preferred) to Liz Cinqueonce , President, and CEO of MN Community Measurement (cinqueonce@mncm.org).
 
The President reviews all appeals and makes recommendations to the MNCM Data Integrity and Use Committee. The Committee makes final decisions on the dispensation of appeals.

We appreciate your time in reviewing these results.
 
Thank you!
MN Community Measurement
Prelim 2024 MY Measure Results for Review_Regular Cycle_PROTECED.xlsx
Prelim 2024 MY Measure Results for Review_DepressionOutcome_Regular Cycle_PROTECTED.xlsx
Get help for this page